Keywords : Impaired fasting glucose
European Journal of Molecular & Clinical Medicine,
2022, Volume 9, Issue 4, Pages 2024-2030
Background: Obesity can alter lipid and carbohydrate metabolism. There is an epidemic rise in obesity in the country. Dyslipidemia (DLP), type 2 diabetes mellitus (DM) and impaired fasting glucose (IFG) has been recognized as a common complication of obesity. Present study was aimed to study clinico-social profile of young obese individuals at a tertiary hospital.
Material and Methods: Present study was single-center, descriptive, observational study, conducted in young individuals (18-40 years age group), with BMI ≥25kg/m2. Results: Among 150 young obese individuals, common age group was between 36 -40 years of age (53.3 %) and the mean age was 34.43 ± 3.76 years. Majority were male (62 %) as compared to female (38 %). Majority cases were in the BMI group of 25-30 kg/m2 (74%) as compared to > 30 kg/m2 (26%). High risk factors such as alcohol consumption (38 %), smoking (43.3 %) & family history of obesity (25.3 %) were also noted. The most common associated comorbidity was dyslipidemia found in 12.7% of cases followed by obstructive sleep apnea (OSA) in 8.7% and then impaired fasting glucose in 8% of cases. 69.3% of cases had no history of comorbidities It was found that impaired fasting glucose was seen in 53.3% of cases where as only 11.3% were having type 2 diabetes mellitus. In this study, it was found that dyslipidemia was seen among 82% of the cases. High TC, LDL and TC/HDL-C ratio was found in 3.3%, 22% and 62.7% of subjects, respectively. Percentage of hypertriglyceridemia was 36.7% among the cases. Low HDL was found in 33.3% of subjects.
Conclusion: Young obese individuals are prone for altered fasting blood sugar (impaired fasting glucose &/and type 2 diabetes mellitus) & dyslipidemia (hypertriglyceridemia and high TC/HDL-C).